Cargando…
Galactosed and Reduction-Responsive Nanoparticles Assembled from Trimethylchitosan–Camptothecin Conjugates for Enhanced Hepatocellular Carcinoma Therapy
The targeted delivery of drugs to tumor cells and prevention of premature release before reaching the target is one of the key challenges to developing nanomedicines. In this paper, galactose decorated trimethyl chitosan (GT)–camptothecin (CPT) prodrug nanoparticles (GT-ss-CPT NPs) were prepared fro...
Autores principales: | Fu, Chen, Qin, Jingcan, Liu, Xinlong, Kong, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316716/ https://www.ncbi.nlm.nih.gov/pubmed/35890209 http://dx.doi.org/10.3390/pharmaceutics14071315 |
Ejemplares similares
-
Preliminary characterization of N-trimethylchitosan as a nanocarrier for malarie vaccine
por: Nnamani, Petra O, et al.
Publicado: (2012) -
Eudragit(®) L100/N-Trimethylchitosan Chloride Microspheres for Oral Insulin Delivery
por: Marais, Etienne, et al.
Publicado: (2013) -
Nanoparticles from Gantrez-based conjugates for the oral delivery of camptothecin
por: Huarte, Judit, et al.
Publicado: (2021) -
Enhanced Liver Targeting of Camptothecin via Conjugation with Deoxycholic Acid
por: Xiao, Linxia, et al.
Publicado: (2019) -
Preparation, characterization and in vivo evaluation of alginate-coated chitosan and trimethylchitosan nanoparticles loaded with PR8 influenza virus for nasal immunization
por: Mosafer, Jafar, et al.
Publicado: (2019)